Indications and uses
relieves vaginal pain, itching, burning and discomfort
relieves vaginal pain, itching, burning and discomfort
Insert 1 applicatorful (2.5cc) into the vagina at bedtime for 14 consecutive nights. Afterwards apply 3 times a week or as needed. Wash applicator after use.
do not use if seal over tube opening has been punctured do not purchase if carton is open store at 20-25°C (68 to 77°F) keep out of direct sunlight
Drug Facts
| Active Ingredients (in each 2.5 g) | Purposes |
|---|---|
| • Sambucus nigra 2x | Irritation reducer tissue repair formula |
| • Echinacea purpurea 3x | Irritation reducer |
| • Hydrocotyle asiatica 3x | Irritation reducer |
For vaginal use only.
If pregnant or breast-feeding, ask a health care professional before use.
Keep out of reach of children. If swallowed, get medical help or contact a poison control center right away.
Insert 1 applicatorful (2.5cc) into the vagina at bedtime for 14 consecutive nights.
Afterwards apply 3 times a week or as needed. Wash applicator after use.
cetyl alcohol, cetyl palmitate, disodium EDTA, hypromellose, methylparaben, polysorbate 60, propylene glycol, silicon dioxide, stearyl alcohol, white petrolatum, water
Call 1-800-956-2595 Monday thru Friday 8am - 5pm EST
Distributed by: Izun Pharmaceuticals Corp.
New York, NY 10022 USA
Herbal Formula
Natural BioActives
NDC 49589-115-60
Natural Vaginal Care
Vaginal Cream
Relieves Vaginal Pain, Itching,
Burning & Discomfort
NET WT
1.4 OZ
(39.7 g)
Homeopathic
izun
Pharmaceuticals

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 49589-115-60 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-1a3b-f424-e053-dadaa90a57ce | Natural Vaginal Care |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49589-115-60 | Natural Vaginal Care | 40 g in 1 TUBE, WITH APPLICATOR | CREAM | 40 | 2 | |
| 49589-115-60 | Natural Vaginal Care | 1 in 1 CARTON | CREAM | 1 | 2 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49589-115 | NATURAL VAGINAL CARE (SAMBUCUS NIGRA FLOWER, ECHINACEA PURPUREA, AND CENTELLA ASIATICA) CREAM [IZUN PHARMACEUTICALS CORPORATION] | 2 | Legacy NDC, 2 package rows | 20150529_a74d5d68-5e31-4126-9987-64dc1fd1521e.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Centella Asiatica | ACTIVE INGREDIENT | 7M867G6T1U | 2 | |
| Echinacea purpurea | ACTIVE INGREDIENT | QI7G114Y98 | 2 | |
| Sambucus nigra flower | ACTIVE INGREDIENT | 07V4DX094T | 2 | |
| Centella Asiatica | ACTIVE MOIETY | 7M867G6T1U | 2 | |
| Echinacea purpurea | ACTIVE MOIETY | QI7G114Y98 | 2 | |
| Sambucus nigra flower | ACTIVE MOIETY | 07V4DX094T | 2 | |
| cetyl alcohol | INACTIVE INGREDIENT | 936JST6JCN | 2 | |
| cetyl palmitate | INACTIVE INGREDIENT | 5ZA2S6B08X | 2 | |
| edetate disodium | INACTIVE INGREDIENT | 7FLD91C86K | 2 | |
| hypromellose 2208 (15000 mpa.s) | INACTIVE INGREDIENT | Z78RG6M2N2 | 2 | |
| methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 2 | |
| petrolatum | INACTIVE INGREDIENT | 4T6H12BN9U | 2 | |
| polysorbate 60 | INACTIVE INGREDIENT | CAL22UVI4M | 2 | |
| propylene glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 2 | |
| silicon dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 2 | |
| stearyl alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 2 | |
| water | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49589-115 | 49589-115-60 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Sambucus nigra flower | 07V4DX094T | ACTIB |
| Echinacea purpurea | QI7G114Y98 | ACTIB |
| Centella Asiatica | 7M867G6T1U | ACTIB |
| cetyl alcohol | 936JST6JCN | IACT |
| cetyl palmitate | 5ZA2S6B08X | IACT |
| edetate disodium | 7FLD91C86K | IACT |
| hypromellose 2208 (15000 mpa.s) | Z78RG6M2N2 | IACT |
| methylparaben | A2I8C7HI9T | IACT |
| polysorbate 60 | CAL22UVI4M | IACT |
| propylene glycol | 6DC9Q167V3 | IACT |
| silicon dioxide | ETJ7Z6XBU4 | IACT |
| stearyl alcohol | 2KR89I4H1Y | IACT |
| petrolatum | 4T6H12BN9U | IACT |
| water | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | TABLET, COATED / ORAL | NA | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION, SOLUTION / EPIDURAL | 30 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED / ORAL | 3 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 19 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | TABLET, ORALLY DISINTEGRATING / ORAL | 3 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | OINTMENT / TOPICAL | 29 mg | ||
| stearyl alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | SUPPOSITORY / VAGINAL | 8.5 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / TOPICAL | 76000 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / AURICULAR (OTIC) | 1 %w/v | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRA-ARTICULAR | 0.05 %w/v | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SUPPOSITORY / VAGINAL | NA | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CLOTH / TOPICAL | 0.03 mg/mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION, EXTENDED RELEASE / ORAL | 70 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / RESPIRATORY (INHALATION) | NA | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LOTION / TOPICAL | 3399 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, ORALLY DISINTEGRATING / ORAL | 68 mg | ||
| polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SUPPOSITORY / RECTAL | 0.05 mg/mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / VAGINAL | 0.1 %w/w | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / AURICULAR (OTIC) | 0.01 %w/v | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | AEROSOL / TOPICAL | 1.16 %w/w | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / SOFT TISSUE | 1 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS | 6 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | JELLY / TOPICAL | 420 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RESPIRATORY (INHALATION) | 0.03 %w/w | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | CREAM, AUGMENTED / TOPICAL | 2 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | NA | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | GEL / OPHTHALMIC | 396 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET / BUCCAL | 3 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | INJECTION / INTRABURSAL | 0.01 %w/v | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / ORAL | 388 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | OINTMENT / OPHTHALMIC | 0.05 %w/w | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SYRUP / ORAL | 81 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| hypromellose 2208 (15000 mpa.s) | HYPROMELLOSE 2208 (15000 MPA.S) | Z78RG6M2N2 | TABLET / BUCCAL | 17 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 2 mg | ||
| cetyl alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET / ORAL | NA | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | POWDER / ORAL | NA | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / PARENTERAL | 18 mg | ||
| petrolatum | PETROLATUM | 4T6H12BN9U | TABLET / ORAL | 3.5 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / RECTAL | 1214 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION/ DROPS / OPHTHALMIC | 0.75 %w/v | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | AEROSOL, FOAM / RECTAL | 2 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUSPENSION / AURICULAR (OTIC) | 10 %w/v | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | CAPSULE / ORAL | 7 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | LOZENGE / ORAL | 120 mg | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | TABLET, COATED / ORAL | 0.8 mg | ||
| polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SUPPOSITORY / VAGINAL | 0.03 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | CREAM / VAGINAL | 3 mg | ||
| cetyl palmitate | CETYL PALMITATE | 5ZA2S6B08X | SOLUTION / TOPICAL | 0.05 %w/w | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE / ORAL | 300 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | LIQUID / ORAL | 162 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SYSTEM / TRANSDERMAL | 35 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | GEL / OPHTHALMIC | 0.44 %w/w | ||
| methylparaben | METHYLPARABEN | A2I8C7HI9T | AEROSOL, FOAM / TOPICAL | 6 mg | ||
| edetate disodium | EDETATE DISODIUM | 7FLD91C86K | SUSPENSION/ DROPS / OPHTHALMIC | 1 mg | ||
| propylene glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | AEROSOL, FOAM / TOPICAL | 1800 mg | ||
| silicon dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | SUSPENSION / ORAL | 400 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 7a7247e7-5513-4c7b-baf9-680eac576525 | a74d5d68-5e31-4126-9987-64dc1fd1521e | 2015-05-27 | Warnings | 7a7247e7-5513-4c7b-baf9-680eac576525 a74d5d68-5e31-4126-9987-64dc1fd1521e |
Adverse event summaries are temporarily unavailable. Other product information remains available.